Signalling inhibition by ponatinib disrupts productive alternative lengthening of telomeres (ALT)

By sjmartinez • April 7, 2023

Kusuma FK, Prabhu A, Tieo G, Ahmed SM, Dakle P, Yong WK, Pathak E, Madan V, Jiang YY, Tam WL, Kappei D, Dröge P, Koeffler HP, Jeitany M. Signalling inhibition by ponatinib disrupts productive alternative lengthening of telomeres (ALT). Nat Commun. 2023 Apr 6;14(1):1919. doi: 10.1038/s41467-023-37633-3. PMID: 37024489.

Tags: Cedars Sinai DoM, Hematology/Oncology, Publications

Artificial intelligence applied to coronary artery calcium scans (AI-CAC) significantly improves cardiovascular events prediction

Naghavi M, Reeves AP, Atlas K, Zhang C, Atlas T, Henschke CI, Yankelevitz DF, Budoff MJ, Li D, Roy SK, Nasir K, Molloi S, Fayad[...]

Machine learning-based clustering identifies obesity subgroups with differential multi-omics profiles and metabolic patterns

Anwar MY, Highland H, Buchanan VL, Graff M, Young K, Taylor KD, Tracy RP, Durda P, Liu Y, Johnson CW, Aguet F, Ardlie KG, Gerszten[...]

Clinical Correlates of a Single-item Physical Activity Questionnaire among Patients Undergoing Stress SPECT Myocardial Perfusion Imaging

Rozanski A, Gransar H, Miller RJ, Han D, Hayes S, Friedman J, Thomson L, Berman D. Clinical Correlates of a Single-item Physical Activity Questionnaire among[...]